Abstract:After the original publication of this article [Chalkias S, McGhee N, Whatley JL et al. Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines. The Journal of Infectious Diseases, jiae067, https://doi.org/10.1093/infdis/jiae067] it was discovered that Figure 1 was missing key data. Figure 1 has been updated in the version currently available online.

Correction: Huang et al. Next Generation of Computationally Optimized Broadly Reactive HA Vaccines Elicited Cross-Reactive Immune Responses and Provided Protection against H1N1 Virus Infection. Vaccines 2021, 9, 793

Correction: Cao et al. Effective Functional Immunogenicity of a DNA Vaccine Combination Delivered via In Vivo Electroporation Targeting Malaria Infection and Transmission. Vaccines 2022, 10, 1134

Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Correction: Khan et al. Oral Immunization of Chickens with Probiotic Lactobacillus crispatus Constitutively Expressing the α-β2-ε-β1 Toxoids to Induce Protective Immunity. Vaccines 2022, 10, 698

Correction: Nian et al. Coping Strategies for Pertussis Resurgence. Vaccines 2023, 11, 889

Correction: Wang Et Al. A VLP-Based Vaccine Displaying HBHA and MTP Antigens of Mycobacterium Tuberculosis Induces Potentially Protective Immune Responses in M. Tuberculosis H37Ra Infected Mice. Vaccines 2023, 11, 941.

Correction: Suleman et al. Immunoinformatics and Immunogenetics-Based Design of Immunogenic Peptides Vaccine against the Emerging Tick-Borne Encephalitis Virus (TBEV) and Its Validation through In Silico Cloning and Immune Simulation. Vaccines 2021, 9, 1210

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Erratum: Comprehensive Analysis of Antibody Recognition in Convalescent Humans from Highly Pathogenic Avian Influenza H5N1 Infection

Correction: Corrigendum: the Changing Shape of Vaccination: Improving Immune Responses Through Geometrical Variations of a Microdevice for Immunization

Corrigendum: COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses.

Author Correction: Mucosal vaccine-induced cross-reactive CD8 + T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection

Correction for Piepenbrink et al., "Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies"

Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023, 11, 510

Correction: Huang et al. Identification of Unique and Conserved Neutralizing Epitopes of Vestigial Esterase Domain in HA Protein of the H9N2 Subtype of Avian Influenza Virus. Viruses 2022, 14, 2739

Correction to: Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines

Correction: Lacy et al. Human Rabies Treatment—From Palliation to Promise. Viruses 2024, 16, 160

Erratum: "Human lung-on-chips: Advanced systems for respiratory virus models and assessment of immune response" [Biomicrofluidics 15, 021501 (2021)]

Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins